美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA213721"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71332-006-12 71332-006 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20240624 N/A NDA NDA213721 Rigel Pharmaceuticals, Inc. PRALSETINIB 100 mg/1 120 CAPSULE in 1 BOTTLE (71332-006-12)
71332-006-60 71332-006 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20240624 N/A NDA NDA213721 Rigel Pharmaceuticals, Inc. PRALSETINIB 100 mg/1 60 CAPSULE in 1 BOTTLE (71332-006-60)
71332-006-90 71332-006 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20240624 N/A NDA NDA213721 Rigel Pharmaceuticals, Inc. PRALSETINIB 100 mg/1 90 CAPSULE in 1 BOTTLE (71332-006-90)
50242-210-12 50242-210 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20220928 N/A NDA NDA213721 Genentech, Inc. PRALSETINIB 100 mg/1 1 BOTTLE in 1 CARTON (50242-210-12) / 120 CAPSULE in 1 BOTTLE
50242-210-60 50242-210 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20210701 N/A NDA NDA213721 Genentech, Inc. PRALSETINIB 100 mg/1 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE
50242-210-83 50242-210 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20210701 N/A NDA NDA213721 Genentech, Inc. PRALSETINIB 100 mg/1 1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE
50242-210-90 50242-210 HUMAN PRESCRIPTION DRUG Gavreto Pralsetinib CAPSULE ORAL 20210701 N/A NDA NDA213721 Genentech, Inc. PRALSETINIB 100 mg/1 1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase